공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 유방암용 단클론항체 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년)

Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028939
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 유방암용 단클론항체 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년) Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 유방암용 단클론항체(Breast Cancer Monoclonal Antibodies) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추이와 예측, 제품·최종사용자·치료법·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 개요, 향후 전망 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 COVID-19의 영향

제5장 시장 규모 및 성장 예측

  • 시장 규모 추이와 예측
  • 성장 촉진요인
  • 성장 억제요인

제6장 시장 분석과 예측 : 각종 구분별

  • 제품별
    • Naked Mabs
    • Conjugated Mabs
  • 최종사용자별
    • 병원
    • 소매 약국
  • 치료별
    • 화학요법
    • 수술/방사선 요법
    • 표적치료
    • 생물학적 요법
    • 호르몬 요법

제7장 시장 분석과 예측 : 지역/국가별

제8장 아시아태평양 시장 분석과 예측

  • 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 법규제, 기관&협회, 조세, 투자, 주요 기업
  • 시장 분석과 예측 : 제품별
  • 시장 분석과 예측 : 최종사용자별

제9장 중국 시장 분석과 예측

제10장 인도 시장 분석과 예측

제11장 일본 시장 분석과 예측

제12장 호주 시장 분석과 예측

제13장 인도네시아 시장 분석과 예측

제14장 한국 시장 분석과 예측

제15장 서유럽 시장 분석과 예측

제16장 영국 시장 분석과 예측

제17장 독일 시장 분석과 예측

제18장 프랑스 시장 분석과 예측

제19장 동유럽 시장 분석과 예측

제20장 러시아 시장 분석과 예측

제21장 북미 시장 분석과 예측

제22장 미국 시장 분석과 예측

제23장 남미 시장 분석과 예측

제24장 브라질 시장 분석과 예측

제25장 중동 시장 분석과 예측

제26장 아프리카 시장 분석과 예측

제27장 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Amgen
    • Mylan
    • Merck
    • Novartis
    • GlaxoSmithKline

제28장 파이프라인 분석

제28장 주요 인수합병(M&A)

제29장 향후 전망과 잠재성 분석

제30장 부록

LSH 21.10.06

Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global breast cancer monoclonal antibodies (mabs) market.

This report focuses on breast cancer monoclonal antibodies (mabs) market which is experiencing strong growth. The report gives a guide to the breast cancer monoclonal antibodies (mabs) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the breast cancer monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Breast Cancer Monoclonal Antibodies (mAbs) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider breast cancer monoclonal antibodies (mabs) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The breast cancer monoclonal antibodies (mabs) market section of the report gives context. It compares the breast cancer monoclonal antibodies (mabs) market with other segments of the breast cancer monoclonal antibodies (mabs) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, breast cancer monoclonal antibodies (mabs) indicators comparison.

Scope

Markets Covered: 1) By Product: Naked Mabs; Conjugated Mabs

2) By End-User: Hospitals; Retail Pharmacies

3) By Treatment: Chemotherapy; Surgery & Radiation Therapy; Targeted Therapy; Biologic Therapy; Hormone Therapy

Companies Mentioned: Amgen; Mylan; Merck; Novartis; GlaxoSmithKline

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Breast Cancer Monoclonal Antibodies Market Characteristics

3. Breast Cancer Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Breast Cancer Monoclonal Antibodies

5. Breast Cancer Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Breast Cancer Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Breast Cancer Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Breast Cancer Monoclonal Antibodies Market Segmentation

  • 6.1. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Naked Mabs
  • Conjugated Mabs
  • 6.2. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Retail Pharmacies
  • 6.3. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Chemotherapy
  • Surgery & Radiation Therapy
  • Targeted Therapy
  • Biologic Therapy
  • Hormone Therapy

7. Breast Cancer Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Breast Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Breast Cancer Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Breast Cancer Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Breast Cancer Monoclonal Antibodies Market

  • 9.1. China Breast Cancer Monoclonal Antibodies Market Overview
  • 9.2. China Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Breast Cancer Monoclonal Antibodies Market

  • 10.1. India Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Breast Cancer Monoclonal Antibodies Market

  • 11.1. Japan Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Breast Cancer Monoclonal Antibodies Market

  • 12.1. Australia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Breast Cancer Monoclonal Antibodies Market

  • 13.1. Indonesia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Breast Cancer Monoclonal Antibodies Market

  • 14.1. South Korea Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Breast Cancer Monoclonal Antibodies Market

  • 15.1. Western Europe Breast Cancer Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Breast Cancer Monoclonal Antibodies Market

  • 16.1. UK Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Breast Cancer Monoclonal Antibodies Market

  • 17.1. Germany Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Breast Cancer Monoclonal Antibodies Market

  • 18.4. France Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Breast Cancer Monoclonal Antibodies Market

  • 19.1. Eastern Europe Breast Cancer Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Breast Cancer Monoclonal Antibodies Market

  • 20.1. Russia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Breast Cancer Monoclonal Antibodies Market

  • 21.1. North America Breast Cancer Monoclonal Antibodies Market Overview
  • 21.2. North America Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Breast Cancer Monoclonal Antibodies Market

  • 22.1. USA Breast Cancer Monoclonal Antibodies Market Overview
  • 22.2. USA Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Breast Cancer Monoclonal Antibodies Market

  • 23.1. South America Breast Cancer Monoclonal Antibodies Market Overview
  • 23.2. South America Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Breast Cancer Monoclonal Antibodies Market

  • 24.1. Brazil Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Breast Cancer Monoclonal Antibodies Market

  • 25.1. Middle East Breast Cancer Monoclonal Antibodies Market Overview
  • 25.2. Middle East Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Breast Cancer Monoclonal Antibodies Market

  • 26.1. Africa Breast Cancer Monoclonal Antibodies Market Overview
  • 26.2. Africa Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Breast Cancer Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Breast Cancer Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Breast Cancer Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Amgen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Mylan
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Merck
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novartis
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. GlaxoSmithKline
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Breast Cancer Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Breast Cancer Monoclonal Antibodies Market

30. Breast Cancer Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q